New products, new channels

Nick Basta, Pharmaceutical Commerce

TRENDS IN BIOPHARMA COLD CHAIN

21,000 SUBSCRIBERS; COMMERCIAL OPS, SALES/MARKETING, SUPPLY CHAIN, REGULATORY COMPLIANCE

The flow of products, information and revenue in the global biopharma industry

Quarterly magazine; annual Sourcebook

’Normal’ distribution

Pharmaceutical Supply Chain from a track-and-trace perspective

Packaging

CMOPallets are shippedSKU in cases

Cases on pallets

All uniquely identified

3PLSCarrier

Pallets or individual cases

get pulled or shipped

Cases and SKUs are

scanned & shipped to

customer

Distribution

Pharmacy

Serial number

scan

Gov

Customer

Distributor

Multiplying distribution channels

On the horizon: personalized cell/gene therapycredit: World Courier

Cold chain products have 2X non-cold-chain growth

In 2018, cold chain is 18% of total pharma spend

Cold chain spend is 71% transport, 29% pkg’g

Air and parcel is the dominant mode

Europe is the largest services market

Clinical trial logistics market is substantial, but slow-growing

Trends to watch:

• International movement is mostly pallet-scale, mostly active container; but passive options are multiplying

• CEIV Pharma program is growing in acceptance, but global practices still vary by country

• How much temperature-controlled CRT shipping? 5-15% in the US, higher in Europe with tighter GDP standards

• How fast will cell/gene therapies grow?

• More reuse of cold-chain packaging is in store: “Cold chain as a service”

• More real-time monitoring of temperature AND external parameters is being offered—but who owns the data?